SUMO Modification of Repression Domains Modulates Function of Nuclear Receptor 5A1 (Steroidogenic Factor-1)
Open accessThe DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
Steroidogenic factor 1 (SF-1 or NR5A1), is a Ftz-F1 member of the nuclear receptor superfamily that plays essential roles in endocrine development, steroidogenesis, and gonad differentiation. We investigated modifications that control SF-1 function and found that SF-1 could be conjugated by SUMO-1 both in vitro and in vivo. SF-1 was modified predominantly at Lys(194) and much less at Lys(119) when free SUMO-1 was supplied. Mutations of Lys(194) and Lys(119) enhanced transcriptional activity of SF-1, although the DNA binding activity of SF-1 was not affected. Sequences around Lys(194) and Lys(119) both repressed transcription intrinsically. The Lys(194) motif repressed transcription more efficiently than the Lys(119) domain, consistent with its ability to be a better substrate for SUMO conjugation. Thus, SUMO modification of SF-1 correlates with transcriptional repression. Wild-type but not conjugation-deficient SF-1 was localized at the nuclear speckles together with SUMO-1. Thus, SUMO-1 conjugation could also target SF-1 into nuclear speckles. Collectively, these results suggest that SUMO modification at the repression domains targets SF-1 to nuclear speckles; this could be an important mechanism by which SF-1 is regulated.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The action of SF1 is modified by other transcription factors (e.g., WT1 and DAX1) (164) or by its phosphorylation (165) or sumoylation (166).”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [166]
Citations
Cites
Mahajan, R., Delphin, C., Guan, T., Gerace, L., & Melchior, F. (1997) · Cell · doi:10.1016/s0092-8674(00)81862-0 · Cited by 1,256
A unified nomenclature system for the nuclear receptor superfamily
(1999) · Cell · doi:10.1016/s0092-8674(00)80726-6 · Cited by 1,208
SUMO-1 Modification of IκBα Inhibits NF-κB Activation
Desterro, J. M. P., Rodriguez, M. S., & Hay, R. T. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80133-1 · Cited by 1,038
Melchior, F. (2000) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.16.1.591 · Cited by 774
Steroidogenic factor 1: a key determinant of endocrine development and function
Parker, K. L., & Schimmer, B. P. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.3.0301 · Cited by 764
Sumo, ubiquitin's mysterious cousin
Müller, S., Hoege, C., Pyrowolakis, G., & Jentsch, S. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35056591 · Cited by 764
Muller, S. (1998) · The EMBO Journal · doi:10.1093/emboj/17.1.61 · Cited by 674
Covalent modification of the androgen receptor by small ubiquitin-like modifier 1 (SUMO-1)
Poukka, H., Karvonen, U., Jänne, O. A., & Palvimo, J. J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.26.14145 · Cited by 457
Phosphorylation of the Nuclear Receptor SF-1 Modulates Cofactor Recruitment
Hammer, G. D., Krylova, I., Zhang, Y., Darimont, B. D., Simpson, K., Weigel, N. L., & Ingraham, H. A. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80480-3 · Cited by 375
SUMO Promotes HDAC-Mediated Transcriptional Repression
Yang, S.-H., & Sharrocks, A. D. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00060-7 · Cited by 353
Research works printed but not linked: 5
- Ueda, 1992, Mol. Cell. Biol., 12, 5667
- Luo, 1995, Mol. Endocrinol., 9, 1233
- Li, 1999, Mol. Endocrinol., 13, 1588, 10.1210/mend.13.9.0349 · doi:10.1210/mend.13.9.0349 · Paper page
- Ito, 1998, Mol. Endocrinol., 12, 290, 10.1210/mend.12.2.0059 · doi:10.1210/mend.12.2.0059 · Paper page
- Ou, 2001, Mol. Endocrinol., 15, 69, 10.1210/mend.15.1.0580 · doi:10.1210/mend.15.1.0580 · Paper page
Cited by
The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders
Miller, W. L., & Auchus, R. J. (2011) · Endocrine Reviews · doi:10.1210/er.2010-0013 · Cited by 2,458
Purification of Proteins Associated with Specific Genomic Loci
Déjardin, J., & Kingston, R. E. (2009) · Cell · doi:10.1016/j.cell.2008.11.045 · Cited by 546
“…including TR2 (Park et al., 2007), are shown to be targeted to the PML-NB or to discrete nuclear bodies (Chalkiadaki and Talianidis, 2005; Chen et al., 2004; Wu et al., 2002), their presence at ALT telomeres could be due to the nonspecific crosslinking of orphan receptors to telomeres…”
Nuclear speckles: molecular organization, biological function and role in disease
Galganski, L., Urbanek, M. O., & Krzyzosiak, W. J. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx759 · Cited by 499
“A substantial portion of NS proteins undergo covalent attachment of ubiquitin or ubiquitin-like proteins, e.g. SUMO1, ISG15 and UBL5.”
BackgroundInfluentialMinireview: steroidogenic factor 1: its roles in differentiation, development, and disease
Schimmer, B. P., & White, P. C. (2010) · Molecular Endocrinology · doi:10.1210/me.2009-0519 · Cited by 268
Molecular aspects of steroidogenic factor 1 (SF-1)
Hoivik, E. A., Lewis, A. E., Aumo, L., & Bakke, M. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.07.003 · Cited by 168
Meinsohn, M.-C., Smith, O. E., Bertolin, K., & Murphy, B. D. (2019) · Physiological Reviews · doi:10.1152/physrev.00019.2018 · Cited by 159
The crystal structures of human steroidogenic factor-1 and liver receptor homologue-1
Wang, W., Zhang, C., Marimuthu, A., Krupka, H. I., Tabrizizad, M., Shelloe, R., Mehra, U., Eng, K., Nguyen, H., Settachatgul, C., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409482102 · Cited by 145
In Search of Adrenocortical Stem and Progenitor Cells
Kim, A. C., Barlaskar, F. M., Heaton, J. H., Else, T., Kelly, V. R., Krill, K. T., Scheys, J. O., Simon, D. P., Trovato, A., Yang, W.-H., et al. (2009) · Endocrine Reviews · doi:10.1210/er.2008-0039 · Cited by 138
“site of Sf1 functions as an intrinsic repression domain (72).”
BackgroundNuclear PI3K signaling in cell growth and tumorigenesis
Davis, W. J., Lehmann, P. Z., & Li, W. (2015) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2015.00024 · Cited by 139
“However, SF-1 can be conjugated with SUMO-1 and thereby targeted to nuclear speckles (Chen et al., 2004).”
BackgroundLee, M. B., Lebedeva, L. A., Suzawa, M., Wadekar, S. A., Desclozeaux, M., & Ingraham, H. A. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.5.1879-1890.2005 · Cited by 118
“results for SF-1 are similar to those of other recent reports (6, 22).”
ResultZhu, J., Chen, L., Sun, G., & Raikhel, A. S. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.01318-06 · Cited by 115
“Moreover, SF-1 activity, in terms of its transactivation, DNA binding, subcellular translocation, and interactions with transcriptional cofactors, is regulated by covalent modifications, such as phosphorylation mediated by mitogen-activated protein kinase, sumoylation, and acetylation by p300 in response to the cyclic…”
BackgroundKomatsu, T., Mizusaki, H., Mukai, T., Ogawa, H., Baba, D., Shirakawa, M., Hatakeyama, S., Nakayama, K. I., Yamamoto, H., Kikuchi, A., et al. (2004) · Molecular Endocrinology · doi:10.1210/me.2004-0173 · Cited by 111
“SUMO-1 modification of Ad4BP/SF-1 has also been observed by Chung and colleagues (60).”
BackgroundNegative Modulation of Androgen Receptor Transcriptional Activity by Daxx
Lin, D.-Y., Fang, H.-I., Ma, A.-H., Huang, Y.-S., Pu, Y.-S., Jenster, G., Kung, H.-J., & Shih, H.-M. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.24.10529-10541.2004 · Cited by 111
“5B. ARND and ARN have higher expression levels than the wild type, whereas ARL and ARDL have a comparable expression level.”
BackgroundInfluentialTranscriptional control of metabolic and inflammatory pathways by nuclear receptor SUMOylation
Treuter, E., & Venteclef, N. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.12.008 · Cited by 119
Tremblay, A. M., Wilson, B. J., Yang, X.-J., & Giguère, V. (2008) · Molecular Endocrinology · doi:10.1210/me.2007-0357 · Cited by 105
Genetic analysis of adrenal absence: agenesis and aplasia
Else, T., & Hammer, G. D. (2005) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2005.10.004 · Cited by 115
SUMO-1 Modification Activated GATA4-dependent Cardiogenic Gene Activity
Wang, J., Feng, X., & Schwartz, R. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407494200 · Cited by 102
Liver receptor homolog-1, an emerging metabolic modulator
Lee, Y., & Moore, D. D. (2008) · Frontiers in bioscience · doi:10.2741/3128 · Cited by 98
“The underlying repression mechanism also appears highly conserved in these two receptors (56, 57).”
BackgroundStructure of SF-1 Bound by Different Phospholipids: Evidence for Regulatory Ligands
Sablin, E. P., Blind, R. D., Krylova, I. N., Ingraham, J. G., Cai, F., Williams, J. D., Fletterick, R. J., & Ingraham, H. A. (2009) · Molecular Endocrinology · doi:10.1210/me.2007-0508 · Cited by 86
Lee, F. Y., Faivre, E. J., Suzawa, M., Lontok, E., Ebert, D., Cai, F., Belsham, D. D., & Ingraham, H. A. (2011) · Developmental Cell · doi:10.1016/j.devcel.2011.06.028 · Cited by 85
“Vertebrate members of the NR5A subfamily of nuclear receptors, including steroidogenic factor 1 (SF-1, NR5A1) and liver receptor homolog 1 (LRH-1, NR5A2), possess two conserved sumoylation sites (Chen et al., 2004; Komatsu et al., 2004; Lee et al., 2005) which are located in the large flexible hinge domain juxtaposed…”
BackgroundResultInfluentialCoactivation of the N-terminal Transactivation of Mineralocorticoid Receptor by Ubc9
Yokota, K., Shibata, H., Kurihara, I., Kobayashi, S., Suda, N., Murai-Takeda, A., Saito, I., Kitagawa, H., Kato, S., Saruta, T., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m607741200 · Cited by 85
Chen, W.-Y., Juan, L.-J., & Chung, B.-C. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.23.10442-10453.2005 · Cited by 79
“full-length SF-1 (7) and visualized by chemiluminescence.”
BackgroundSelf-citationWinnay, J. N., & Hammer, G. D. (2006) · Molecular Endocrinology · doi:10.1210/me.2005-0215 · Cited by 74
Adrenocortical stem and progenitor cells: Unifying model of two proposed origins
Wood, M. A., & Hammer, G. D. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.11.012 · Cited by 74
Steroidogenic factor-1 is a sphingolipid binding protein
Urs, A. N., Dammer, E. B., Kelly, S. L., Wang, E. L., Merrill, A. H., & Sewer, M. B. (2006) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2006.12.016 · Cited by 70
“The ability of SF1 to activate target gene expression is also regulated by SOMUylation (Chen et al., 2004; Komatsu et al., 2004; Lee et al., 2005), acetylation (Chen et al., 2005; Ishihara and Morohashi, 2005; Jacob et al., 2001), and interaction with various coregulatory proteins (Chen et al., 2005).”
BackgroundMultiple Roles for Sphingolipids in Steroid Hormone Biosynthesis
Lucki, N. C., & Sewer, M. B. (2008) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-1-4020-8831-5_15 · Cited by 86
“The ability of SF-1 to bind to target genes is regulated by post-translational modifications including phosphorylation and acetylation (Chen et al., 2004; Hammer et al., 1999; Ishihara and Morohashi, 2005).”
BackgroundHedgehog Signaling and Steroidogenesis
Finco, I., LaPensee, C. R., Krill, K. T., & Hammer, G. D. (2015) · Annual Review of Physiology · doi:10.1146/annurev-physiol-061214-111754 · Cited by 76
Scavenger Receptors Mediate the Role of SUMO and Ftz-f1 in Drosophila Steroidogenesis
Talamillo, A., Herboso, L., Pirone, L., Pérez, C., González-Lopez, M., Sánchez, J., Mayor, U., Lopitz‐Otsoa, F., Rodríguez, M. S., Sutherland, J. D., et al. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003473 · Cited by 76
Minireview: Steroidogenic Factor 1: Its Roles in Differentiation, Development, and Disease
Schimmer, B. P., & White, P. C. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.95.3.9994 · Cited by 66
SUMOylation Inhibits SF-1 Activity by Reducing CDK7-Mediated Serine 203 Phosphorylation
Yang, W., Heaton, J. H., Brevig, H., Mukherjee, S., Iñiguez-Lluhí, J. A., & Hammer, G. D. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00295-08 · Cited by 65
“Recent reports have demonstrated that SF-1 harbors functional SC motifs and that SUMOylation of SF-1 attenuates its transcriptional activity in a promoter context-dependent manner (11, 40, 42).”
BackgroundResultInfluentialDecreased Recognition of SUMO-Sensitive Target Genes following Modification of SF-1 (NR5A1)
Campbell, L. A., Faivre, E. J., Show, M. D., Ingraham, J. G., Flinders, J., Gross, J. D., & Ingraham, H. A. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00103-08 · Cited by 59
“Although earlier studies suggested that SUMO-modified SF-1 retains the ability to bind DNA, these studies were unable to separately assess the binding of the sumoylated SF-1 from unmodified SF-1 (8, 31).”
BackgroundLi, D., Urs, A. N., Allegood, J., Leon, A., Merrill, A. H., & Sewer, M. B. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00355-07 · Cited by 58
Weck, J., & Mayo, K. E. (2006) · Molecular Endocrinology · doi:10.1210/me.2005-0199 · Cited by 64
Chen, W., Weng, J., Huang, C. J., & Chung, B. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00476-07 · Cited by 60
“However, mutations of SF-1 at sites of phospholipid interaction, sumoylation, acetylation, and phosphorylation did not change SF-1 levels (10, 11, 15, 24).”
BackgroundSelf-citationYang, F., Pan, C., Tsai, H., Chiu, T., Wu, M., & Hu, M. (2008) · FEBS Journal · doi:10.1111/j.1742-4658.2008.06785.x · Cited by 69
Holmstrom, S. R., Chupreta, S., So, A. Y.-L., & Iñiguez-Lluhí, J. A. (2008) · Molecular Endocrinology · doi:10.1210/me.2007-0581 · Cited by 53
“Dimerization per se, however, is not an essential requirement because activators that act through monomeric contacts with DNA including ETS-1, steroidogenic factor 1, GATA-2, SP3, and the Ets-1 like protein Elk-1 (6, 18, 20, 21, 23, 63) are also subject to SUMOylation-dependent synergy control.”
BackgroundChang, T.-H., Xu, S., Tailor, P. B., Kanno, T., & Ozato, K. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1201104 · Cited by 54
“To further solidify IRF8 SUMO conjugation in vivo, NIH3T3 cells were transfected with CFP-IRF8 and YFP-SUMO3, or YFP-mutant SUMO3 (SUMO3GA), in which the C-terminal amino acids GG were mutated to AA, eliminating the SUMOylation activity (42).”
MethodE3 Ubiquitin Ligase RNF31 Cooperates with DAX-1 in Transcriptional Repression of Steroidogenesis
Ehrlund, A., Anthonisen, E. H., Gustafsson, N., Venteclef, N., Remen, K. M. R., Damdimopoulos, A. E., Galeeva, A., Pelto‐Huikko, M., Lalli, E., Steffensen, K. R., et al. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00743-08 · Cited by 55
“These studies suggest that phosphorylation and acetylation stimulate SF-1 activity (6) (15), SUMOylation inactivates SF-1 (7), and polyubiquitination triggers proteasomal degradation of SF-1 (8).”
BackgroundAdrenocortical development and cancer: focus on SF-1
Lalli, E. (2010) · Journal of Molecular Endocrinology · doi:10.1677/jme-09-0143 · Cited by 51
“…modifications, namely phosphorylation by different kinases at Ser203 (Hammer et al. 1999, Lewis et al. 2008) and sumoylation, which may affect subnuclear localization of SF-1 and its DNA-binding activity (Chen et al. 2004, Komatsu et al. 2004, Lee et al. 2005, Campbell et al. 2008).”
BackgroundThe role of SUMOylation during development
Talamillo, A., Barroso‐Gomila, O., Giordano, I., Ajuria, L., Grillo, M., Mayor, U., & Barrio, R. (2020) · Biochemical Society Transactions · doi:10.1042/bst20190390 · Cited by 56
Kurihara, I., Shibata, H., Kobayashi, S., Suda, N., Ikeda, Y., Yokota, K., Murai, A., Saito, I., Rainey, W. E., & Saruta, T. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m411820200 · Cited by 46
Liang, N., Xu, Y., Yin, Y., Yao, G., Tian, H., Wang, G., Lian, J., Wang, Y., & Sun, F. (2011) · Endocrinology · doi:10.1210/en.2011-0102 · Cited by 45
Ahmed, J., Mészáros, A., Lázár, T., & Tompa, P. (2021) · Protein Science · doi:10.1002/pro.4100 · Cited by 46
Johnston, R., & Hobert, O. (2005) · Development · doi:10.1242/dev.02163 · Cited by 46
“For example, nuclear speckle localization has been reported for transcription factors such as ALL1/Trithorax, steroid receptor co-activator (SRC-1), steroidogenic factor 1 (SF-1) and Pnn/DRS (Alpatov et al., 2004; Amazit et al., 2003; Chen et al., 2004; Zeng et al., 1997).”
BackgroundHuang, S., Huang, S., Wang, S.-L., & Liu, P. (2007) · Biochemical Journal · doi:10.1042/bj20061295 · Cited by 39
Kuo, F., Bentsi-Barnes, I. K., Barlow, G. M., Bae, J., & Pisarska, M. D. (2009) · Cellular Signalling · doi:10.1016/j.cellsig.2009.09.001 · Cited by 44
Sumoylated NHR-25/NR5A Regulates Cell Fate during C. elegans Vulval Development
Ward, J. D., Bojanala, N., Bernal, T. U., Ashrafi, K., Asahina, M., & Yamamoto, K. R. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003992 · Cited by 35
Shyu, Y., Lee, T., Ting, C., Wen, S.-C., Hsieh, L., Li, Y.-C., Hwang, J.-L., Lin, C., & Shen, C. ‐. J. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.23.10365-10378.2005 · Cited by 33
“pFlagDsRed2-SUMO-1 GG and pFlagDsRed2-SUMO-1 AA were provided by B. C. Chung ( 12 ).”
MethodComplex assembly on the human CYP17 promoter
Sewer, M. B., & Jagarlapudi, S. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.10.006 · Cited by 31
Wang, C., Kao, Y.-H., Lai, P.-Y., Chen, W., & Chung, B. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.01064-12 · Cited by 31
“sera against SF-1 (23) have been described previously.”
BackgroundSelf-citationMatulis, C. K., & Mayo, K. E. (2012) · Molecular Endocrinology · doi:10.1210/me.2011-1347 · Cited by 31
Ehrlund, A., Jonsson, P., Vedin, L., Williams, C., Gustafsson, J.-Å., & Treuter, E. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032080 · Cited by 35
“Phosphorylation of residues in the hinge region by kinases in the MAPK pathway enhances SF-1-dependent transcription [22] while SUMOylation of lysine residues in the same region can repress SF-1 [23,24,25,26].”
BackgroundLardone, M. C., Argandoña, F., Lorca, M., Piottante, A., Flórez, M., Palma, C., Ebensperger, M., & Andrea Castro, G. (2018) · Molecular Human Reproduction · doi:10.1093/molehr/gay006 · Cited by 29
“Moreover, cAMP signaling may induce SF-1 phosphorylation and other post-translational modifications, such as acetylation and SUMOylation, which control the transactivation function of this receptor in steroidogenic cells (Chen et al., 2004, 2005).”
BackgroundLucki, N. C., Li, D., Bandyopadhyay, S., Wang, E. L., Merrill, A. H., & Sewer, M. B. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.00378-12 · Cited by 31
“The ability of SF-1 to bind to target promoters is regulated by posttranslational modifications, including phosphorylation (13, 21, 63, 64), sumoylation (7, 31), and acetylation (6, 27, 30), as well as protein-protein interactions (5, 12, 37, 45, 61, 79, 82).”
BackgroundTiming of adrenal regression controlled by synergistic interaction between Sf1 SUMOylation and Dax1
Xing, Y., Morohashi, K.-I., Ingraham, H. A., & Hammer, G. D. (2017) · Development · doi:10.1242/dev.150516 · Cited by 27
“Previous studies have indicated that SUMOylation of Sf1 does not alter its nuclear localization or DNA interaction (Chen et al., 2004; Lee et al., 2005), both of which are confirmed in the current study (data not shown).”
BackgroundSteroidogenic Factor 1 and the Central Nervous System
Büdefeld, T., Tobet, S. A., & Majdič, G. (2011) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2011.02174.x · Cited by 29
Ogawa, H., Komatsu, T., Hiraoka, Y., & Morohashi, K.-I. (2009) · Molecular Biology of the Cell · doi:10.1091/mbc.e08-12-1247 · Cited by 27
Paradoxes of Cellular SUMOylation Regulation: A Role of Biomolecular Condensates?
Cheng, X., Yang, W., Lin, W., & Mei, F. C. (2023) · Pharmacological Reviews · doi:10.1124/pharmrev.122.000784 · Cited by 25
When PIP2 Meets p53: Nuclear Phosphoinositide Signaling in the DNA Damage Response
Wang, Y., & Sheetz, M. P. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.903994 · Cited by 28
“Intriguingly, SUMOylation of NR5A1 drives NR5A1 to localize at nuclear speckles (Chen et al., 2004).”
BackgroundSumoylation of histone deacetylase 1 regulates MyoD signaling during myogenesis
Joung, H., Kwon, S., Kim, K. H., Lee, Y.-G., Shin, S., Kwon, D., Lee, Y.-U., Kook, T., Choe, N., Kim, J. C., et al. (2018) · Experimental & Molecular Medicine · doi:10.1038/emm.2017.236 · Cited by 24
Cai, K., Lucki, N. C., & Sewer, M. B. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2013.12.005 · Cited by 24
Priyanka, P., Kotiya, D., Rana, M., Subbarao, N., Puri, N., & Tyagi, R. K. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.11.001 · Cited by 22
Coactivation of SF-1-Mediated Transcription of Steroidogenic Enzymes by Ubc9 and PIAS1
Suda, N., Shibata, H., Kurihara, I., Ikeda, Y., Kobayashi, S., Yokota, K., Murai‐Takeda, A., Nakagawa, K., Oya, M., Murai, M., et al. (2011) · Endocrinology · doi:10.1210/en.2010-1232 · Cited by 22
SUMOylation in the control of cholesterol homeostasis
Talamillo, A., Ajuria, L., Grillo, M., Barroso‐Gomila, O., Mayor, U., & Barrio, R. (2020) · Open Biology · doi:10.1098/rsob.200054 · Cited by 25
Relav, L., Doghman, M., Ruggiero, C., Muzzi, J. C. D., de Figueiredo, B. C., & Lalli, E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043585 · Cited by 28
“The localization of SUMOylated SF-1 is restricted to nuclear speckles, thus, preventing its DNA-binding activity [65,84].”
BackgroundLan, H.-C., Wu, C., Shih, H., & Chung, B. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.307603 · Cited by 19
Self-citationCai, K., & Sewer, M. B. (2013) · Journal of Lipid Research · doi:10.1194/jlr.m035634 · Cited by 18
The Ftz‐F1 family: Orphan nuclear receptors regulated by novel protein–protein interactions
Pick, L., Anderson, W. R., Shultz, J. W., & Woodard, C. T. (2006) · Advances in developmental biology · doi:10.1016/s1574-3349(06)16008-1 · Cited by 17
Lalli, E. (2010) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2010.10.009 · Cited by 21
Distinct functions of steroidogenic factor-1 (NR5A1) in the nucleus and the centrosome
Wang, C., Chen, W., Lai, P.-Y., & Chung, B. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.11.019 · Cited by 15
“, 2007), and conjugation SF-1 by a small ubiquitin like modulator (SUMO) leads to the repression of SF-1 activity (Chen et al., 2004).”
BackgroundSelf-citationcAMP-dependent regulation of CYP19 gene in rabbit preovulatory granulosa cells and corpus luteum
Andrieu, T., Pezzi, V., Sirianni, R., Bas, R. L., Féral, C., Benhaïm, A., & Mittre, H. (2009) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2009.05.003 · Cited by 15
Lee, J., Yang, D. J., Lee, S., Hammer, G. D., Kim, K. W., & Elmquist, J. K. (2016) · Scientific Reports · doi:10.1038/srep19143 · Cited by 16
Degerny, C., de Launoit, Y., & Baert, J. (2008) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2008.01.002 · Cited by 15
Wang, C., Lai, P.-Y., Chen, T.-Y., & Chung, B. (2014) · Cell Communication and Signaling · doi:10.1186/s12964-014-0055-9 · Cited by 17
“The immune sera against SF-1 have been described previously [19].”
BackgroundSelf-citationA matter of dosage: SF-1 in adrenocortical development and cancer
Doghman, M., & Lalli, E. (2009) · Annales d Endocrinologie · doi:10.1016/j.ando.2009.02.002 · Cited by 13
SUMOylation of Warts kinase promotes neural stem cell reactivation
Gao, Y., Tan, Y. S., Lin, J., Chew, L. Y., Aung, H. Y., Palliyana, B., Gujar, M. R., Lin, K., Kondo, S., & Wang, H. (2024) · Nature Communications · doi:10.1038/s41467-024-52569-y · Cited by 11
“In addition, 46.8% of Dpn+ cells in lwr 13 optic lobes were EdU-negative, while all Dpn+ cells in the control optic lobe were EdU-positive.”
InfluentialHormonal and spatial control of SUMOylation in the human and mouse adrenal cortex
Dumontet, T., Sahut‐Barnola, I., Dufour, D., Lefrançois‐Martinez, A., Berthon, A. S., Montanier, N., Ragazzon, B., Djari, C., Pointud, J., Roucher‐Boulez, F., et al. (2019) · The FASEB Journal · doi:10.1096/fj.201900557r · Cited by 13
Not So Slim Anymore—Evidence for the Role of SUMO in the Regulation of Lipid Metabolism
Sapir, A. (2020) · Biomolecules · doi:10.3390/biom10081154 · Cited by 12
Generation of Rat Monoclonal Antibodies Specific for Ad4BPSF-1
Yokoyama, C., Komatsu, T., Ogawa, H., Morohashi, K.-I., Azuma, M., & Tachibana, T. (2009) · Hybridoma · doi:10.1089/hyb.2008.0084 · Cited by 12
Duck PIAS2 Promotes H5N1 Avian Influenza Virus Replication Through Its SUMO E3 Ligase Activity
Zu, S., Xue, Q., He, Z., Shi, C., Zhang, J., Wu, W., Li, W., Liu, Z., Huang, J., Jiao, P., et al. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01246 · Cited by 10
Steroidogenic Factor 1 (NR5A1) Activates ATF3 Transcriptional Activity
Emura, N., Wang, C., Yang, W. H., & Yang, W. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041429 · Cited by 10
SUMO and ubiquitin modifications during steroid hormone synthesis and function
Talamillo, A., Martín, D., Hjerpe, R., Sánchez, J., & Barrio, R. (2010) · Biochemical Society Transactions · doi:10.1042/bst0380054 · Cited by 13
Identification and Characterization of Steroidogenic Factor-1 Inverse Agonists
Doghman, M., Madoux, F., Hodder, P., & Lalli, E. (2010) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/b978-0-12-381296-4.00001-4 · Cited by 8
“…(Hammer et al., 1999; Lewis et al., 2008) and sumoylation, affecting SF-1 subnuclear localization and DNA-binding activity (Campbell et al., 2008; Chen et al., 2004; Komatsu et al., 2004; Lee et al., 2005), and (2) interaction with positive and negative cofactors (reviewed inHoivik et al., 2010).”
BackgroundKang, L., Wang, X., Wang, J., Guo, J., Zhang, W., & Lei, R. (2023) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2023.130500 · Cited by 7
Acidic Residue Glu199 Increases SUMOylation Level of Nuclear Hormone Receptor NR5A1
Wang, C., Liu, R., Wang, L., & Yang, W. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms141122331 · Cited by 7
“SUMO modification of NR5A1 has a strong influence on its transcriptional activity as evidenced by that NR5A1 transcriptional activity is intensively inhibited by SUMOylation [37,47,51].”
BackgroundResultProtein SUMOylation and Its Functional Role in Nuclear Receptor Control
Wild, N., Kaiser, C. S., Wunderlich, G., Liebau, E., & Wrenger, C. (2024) · Receptors · doi:10.3390/receptors3030020 · Cited by 6
Steroidogenic Cytochrome P450 Gene CYP11A1: Functions and Regulation
Shih, M. M.-C., Hsu, H., Lan, H.-C., Weng, J., Chien, Y., Hu, M., & Chung, B. (2014) · Springer eBooks · doi:10.1007/978-4-431-54992-5_15 · Cited by 6
“They are instead regulated mainly by translational modifications such as sumoylation (Chen et al. 2004; Lee et al. 2011), acetylation (Chen et al.”
Self-citationSUMO Modification and Transcriptional Regulation
Iñiguez-Lluhí, J. A. (2009) · Springer eBooks · doi:10.1007/978-90-481-2649-1_2 · Cited by 5
Umair, Z., Nawaz, Z., Hasnain, S., & Fischle, W. (2025) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-025-05825-3 · Cited by 4
Wang, C., Lai, P.-Y., Chen, T.-Y., & Chung, B. (2014) · Cell Communication and Signaling · doi:10.1186/preaccept-5504843801263919 · Cited by 2
Self-citationDiacylglycerol kinases: Molecular mechanism of cellular and physiological functions
Kimura, T., & Epand, R. M. (2026) · Progress in Lipid Research · doi:10.1016/j.plipres.2025.101373 · Cited by 2
Wang, Q. (2013) · uO Research (University of Ottawa) · doi:10.20381/ruor-2980 · Cited by 1
Estudio genético y funcional de NR5A2, un factor de transcripción ligado a obesidad y diabetes
Bolado‐Carrancio, A. (2013) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 1
Murphy, C. A. (2010) · ScholarlyCommons (University of Pennsylvania)
Ehrlund, A. (2011) · Figshare
Functions of the coregulator protein SNURF (RNF4) in transcription and cell growth
Häkli, M. (2005) · Helda - University of Helsinki Institutional Repository
Brion, L. (2010) · Repositorio Digital Institucional de la Universidad de Buenos Aires (Universidad de Buenos Aires)
Small Ubiquitin-Related Modifier-1 Programs Granulosa the Cell Apoptosis in Mice Ovary
Yang, F. (2019) · Pakistan Veterinary Journal · doi:10.29261/pakvetj/2019.098
Steroidogenic Factor 1 (SF-1; NR5A1)
McElreavey, K., & Bashamboo, A. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.65242-x
McElreavey, K., & Bashamboo, A. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00372-1
Metadata
- Authors
- Chen, W.-Y., Lee, W.-C., Hsu, N.-C., Huang, F., & Chung, B.-C.
- Affiliations
- Institute of Molecular Biology, Academia Sinica (TW)
- National Tsing Hua University (TW)
- Corresponding author
- Chung, Bon-chu
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2004-09
- Volume
- 279
- Issue
- 37
- Pages
- 38730-38735
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2015882117
- Semantic Scholar
- 5ff0759775b569fc74d24ef79d6fea7a95c09359
- Cited by
- 104
- References
- 31
- Citations by year
- 2026: 3 · 2025: 1 · 2024: 2 · 2023: 3 · 2022: 1 · 2021: 1 · 2020: 5 · 2019: 4 · 2018: 3 · 2017: 3 · 2016: 1 · 2015: 3 · 2014: 3 · 2013: 8 · 2012: 6
- FWCI
- 3.75
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 5890 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Keywords
- steroidogenic factor 1, SUMOylation, repression domain, transcriptional repression, nuclear speckles, transcriptional activity, steroidogenesis, gonad differentiation, lysine modification sites
- MeSH terms
- Animals, Binding Sites, Cell Nucleus, DNA, DNA-Binding Proteins, Luciferases, Luminescent Proteins, Lysine, Microscopy, Fluorescence, Mutation, Plasmids, Protein Binding, Transcription Factors, Transcription, Genetic, Transfection, Immunoblotting, Protein Structure, Tertiary, Receptors, Cytoplasmic and Nuclear, Homeodomain Proteins, Microscopy, Confocal, SUMO-1 Protein, NIH 3T3 Cells, Green Fluorescent Proteins, Mice, Fushi Tarazu Transcription Factors, Steroidogenic Factor 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.